MLN8237 further pushes the neuroblastoma cell past the apoptotic threshold through reduction of MCL-1; BCL-xL is ineffective at blocking the ensuing death signal because BCL-xL levels are markedly low. The gene discussed is BCL2L1; the disease is neuroblastoma.